| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 25, 2005
Accepted on November 2, 2005
Department of Endocrinology, Christie Hospital, Manchester, UK and Clinical Radiology, Imaging Science and Biomedical Engineering, the University of Manchester, UK
* To whom correspondence should be addressed. E-mail: stephen.m.shalet{at}man.ac.uk.
Context: Low bone mass is a characteristic feature of the adult GHD syndrome, however, recent dual energy x-ray absorptiometry (DXA) studies in patients with GH-receptor and GHRH-receptor gene mutations suggest the situation is more complex.
Objective: To define bone areal and volumetric densities, and morphometry in hypopituitary adults.
Design: The study was a cross-sectional case controlled study performed between 1999 and 2001.
Setting: The study was undertaken at an endocrine tertiary referral center.
Patients: 30 patients with GHD, 24 with GH insufficiency (GHI, peak GH 3 - 7 µg/l [9 - 21mU/l]), and 30 age and sex-matched controls.
Main Outcome Measure: DXA and peripheral quantitative computed tomography (pQCT) derived bone density and morphometry.
Results: No densitometric or morphometric abnormalities were detected in GHD patients who acquired their deficiency during adult life (AO-GHD). GHD adults of childhood-onset (CO-GHD) showed decreased BMD at the lumbar spine and hip on DXA. pQCT of the radius showed CO-GHD patients have normal trabecular BMD, and only a 2% decrease in cortical density. Radial bone area was reduced 14.5%, cortical thickness 20%, and cortical cross-sectional area 23% culminating in a reduction in cortical bone of 25%. The \'apparent' low DXA bone density in CO-GHD adults therefore relates primarily to reduced cortical thickness and smaller bone area. DXA and pQCT data derived from adults with GHI revealed no evidence of densitometric or morphometric abnormalities.
Conclusions: (1) AO-GHD patients have normal bone density and size (2). CO-GHD adults have marginally reduced cortical density, but significantly reduced cortical bone as a result of reduced cortical thickness and bone size (3). GHI has no measurable impact on the skeleton.
This article has been cited by other articles:
![]() |
A. Giustina, G. Mazziotti, and E. Canalis Growth Hormone, Insulin-Like Growth Factors, and the Skeleton Endocr. Rev., August 1, 2008; 29(5): 535 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Murray, M. Bidlingmaier, C. J. Strasburger, and S. M. Shalet The Diagnosis of Partial Growth Hormone Deficiency in Adults with a Putative Insult to the Hypothalamo-Pituitary Axis J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1705 - 1709. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |